Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2Phase 2/3 1Phase 2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 8Neoplasms 6Head and Neck Neoplasms 6Prostatic Neoplasms 5Oropharyngeal Neoplasms 5Lung Neoplasms 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Neoplasm Metastasis 4Myasthenia Gravis 4Lymphoma, Large B-Cell, Diffuse 4Cholangiocarcinoma 4Recurrence 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Mouth Neoplasms 3Leukemia, Myeloid, Acute 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Glioblastoma 3Fatigue 3Endometrial Neoplasms 3Carcinoma 3Breast Neoplasms 3Weight Loss 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Nasopharyngeal Carcinoma 2Melanoma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Nasopharyngeal Neoplasms × 30 days × Clear all
NCT06851663 2026-05-29

Trop2-targeted immunoPET Imaging of Solid Tumors

RenJi Hospital

Phase 2/3 Recruiting
400 enrolled
GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡